Advanced search
Publication Cover
Acta Oncologica Volume 46, 2007 - Issue 8
Journal homepage
4,354
Views
66
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Incidence and characteristics of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer

Andreas A. Argyriou Department of Neurology-EMG Laboratory, University of Patras Medical School, Rion-Patras, GreeceCorrespondence[email protected]
,
Panagiotis Polychronopoulos Department of Neurology-EMG Laboratory, University of Patras Medical School, Rion-Patras, Greece
,
Gregoris Iconomou Department of Medicine-Division of Oncology, University of Patras Medical School, Rion-Patras, Greece
,
Angelos Koutras Department of Medicine-Division of Oncology, University of Patras Medical School, Rion-Patras, Greece
,
Thomas Makatsoris Department of Medicine-Division of Oncology, University of Patras Medical School, Rion-Patras, Greece
,
Miltiadis K. Gerolymos Department of Medicine-Division of Oncology, University of Patras Medical School, Rion-Patras, Greece
,
Philippos Gourzis Department of Medicine-Division of Oncology, University of Patras Medical School, Rion-Patras, Greece
,
Konstantinos Assimakopoulos Department of Medicine-Division of Oncology, University of Patras Medical School, Rion-Patras, Greece
,
Haralabos P. Kalofonos Department of Medicine-Division of Oncology, University of Patras Medical School, Rion-Patras, Greece
&
Elisabeth Chroni Department of Neurology-EMG Laboratory, University of Patras Medical School, Rion-Patras, Greece
 show all
Pages 1131-1137 | Received 05 Oct 2006, Published online: 08 Jul 2009

Citations (66)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Hong-Mei Lin, Long-Fei Lin, Zhen-Zhen Xia, Yong Mao, Jia Liu, Ling-Yan Xu & Qing Wu. (2018) Neuroprotective effects and UPLC-Q-TOF/MS-based active components identification of external applied a novel Wen-Luo-Tong microemulsion. Artificial Cells, Nanomedicine, and Biotechnology 46:8, pages 1981-1991.
Read now
Andreas A Argyriou, Athanasios P Kyritsis, Thomas Makatsoris & Haralabos P Kalofonos. (2014) Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature. Cancer Management and Research 6, pages 135-147.
Read now

Articles from other publishers (64)

Allison B. Wang, Stephen N. Housley, Daniel Ludvig, Colin K. Franz, Ann Marie Flores, Timothy C. Cope & Eric J. Perreault. (2023) Cancer survivors post-chemotherapy exhibit unimpaired short-latency stretch reflexes in the proximal upper extremity. Journal of Neurophysiology 130:4, pages 895-909.
Crossref
Fang Cheng, Ruoqi Zhang, Chen Sun, Qian Ran, Cuihan Zhang, Changhong Shen, Ziqing Yao, Miao Wang, Lin Song & Cheng Peng. (2023) Oxaliplatin-induced peripheral neurotoxicity in colorectal cancer patients: mechanisms, pharmacokinetics and strategies. Frontiers in Pharmacology 14.
Crossref
Daniel White, Munawwar Abdulla, Susanna B. Park, David Goldstein, Gila Moalem‐Taylor & Justin G. Lees. (2023) Targeting translation: A review of preclinical animal models in the development of treatments for chemotherapy‐induced peripheral neuropathy. Journal of the Peripheral Nervous System 28:2, pages 179-190.
Crossref
Susanna B Park, Aysel Cetinkaya-Fisgin, Andreas A Argyriou, Ahmet Höke, Guido Cavaletti & Paola Alberti. (2023) Axonal degeneration in chemotherapy-induced peripheral neurotoxicity: clinical and experimental evidence. Journal of Neurology, Neurosurgery & Psychiatry, pages jnnp-2021-328323.
Crossref
Wei Tian, Lina Zhang, Xiao Liu, Xiao Ma & Rui Wang. (2023) Fluoropyrimidine combination therapy versus fluoropyrimidine monotherapy for gemcitabine-refractory advanced pancreatic cancer: A systematic review and meta-analysis of randomized controlled trials. PLOS ONE 18:3, pages e0282360.
Crossref
Merve Albayrak, Carolina Figueras, Elia Seguí, Michela Campolo, Eva Gabarrón, Reinaldo Moreno, Joan Maurel & Jordi Casanova-Molla. (2022) Prognostic value of cutaneous reinnervation with GAP-43 in oxaliplatin-induced neuropathy. Journal of Neurology 269:8, pages 4174-4184.
Crossref
Xuelin Huang, Jie Deng, Ting Xu, Wenjun Xin, Yuehong Zhang & Xiangcai Ruan. (2021) Downregulation of metallothionein-2 contributes to oxaliplatin-induced neuropathic pain. Journal of Neuroinflammation 18:1.
Crossref
R. Bonomo & G. Cavaletti. (2021) Clinical and biochemical markers in CIPN: A reappraisal. Revue Neurologique 177:8, pages 890-907.
Crossref
N. Paniagua, E.M. Sánchez-Robles, A. Bagues, M.I. Martín-Fontelles, C. Goicoechea & R. Girón. (2021) Behavior and electrophysiology studies of the peripheral neuropathy induced by individual and co-administration of paclitaxel and oxaliplatin in rat. Life Sciences 277, pages 119397.
Crossref
Andreas A. Argyriou, Foteini Kalofonou, Pantelis Litsardopoulos, Garifallia G. Anastopoulou & Haralabos P. Kalofonos. (2020) Oxaliplatin rechallenge in metastatic colorectal cancer patients with clinically significant oxaliplatin‐induced peripheral neurotoxicity. Journal of the Peripheral Nervous System 26:1, pages 43-48.
Crossref
Jessica Marie Gajda, Marina Asiedu, Gladys Morrison, Jacqueline Ann Dunning, Nayereh Ghoreishi-Haack & Amanda Lynn Barth. (2021) NYX-2925, A NOVEL, NON-OPIOID, SMALL-MOLECULE MODULATOR OF THE N-METHYL-d-ASPARTATE RECEPTOR (NMDAR), DEMONSTRATES POTENTIAL TO TREAT CHRONIC, SUPRASPINAL CENTRALIZED PAIN CONDITIONS. Medicine in Drug Discovery 9, pages 100067.
Crossref
Gisele Graça Leite dos Santos, Anna Lethícia Lima Oliveira, Dourivaldo Silva Santos, Renan Fernandes do Espírito Santo, Daniela Nascimento Silva, Paulo José Lima Juiz, Milena Botelho Pereira Soares & Cristiane Flora Villarreal. (2021) Mesenchymal stem cells reduce the oxaliplatin-induced sensory neuropathy through the reestablishment of redox homeostasis in the spinal cord. Life Sciences 265, pages 118755.
Crossref
Nadire Özenver & Thomas Efferth. 2021. Medicinal Herbs and Fungi. Medicinal Herbs and Fungi 1 35 .
Nazanin Bondad, Reza Boostani, Alireza Barri, Sepideh Elyasi & Abolghasem Allahyari. (2020) Protective effect of N-acetylcysteine on oxaliplatin-induced neurotoxicity in patients with colorectal and gastric cancers: A randomized, double blind, placebo-controlled, clinical trial. Journal of Oncology Pharmacy Practice 26:7, pages 1575-1582.
Crossref
Selda Arslan, Pinar Zorba Bahceli, Yeter İlik & Mehmet Artaç. (2020) The preliminary effects of henna on chemotherapy-induced peripheral neuropathy in women receiving oxaliplatin-based treatment: A parallel-group, randomized, controlled pilot trial. European Journal of Oncology Nursing 48, pages 101827.
Crossref
Christina Teng, Stephanie E. Reuter, Prunella L. Blinman, Haryana M. Dhillon, Peter Galettis, Nicholas Proschogo, Andrew J. McLachlan & Janette L. Vardy. (2020) Ibudilast for prevention of oxaliplatin-induced acute neurotoxicity: a pilot study assessing preliminary efficacy, tolerability and pharmacokinetic interactions in patients with metastatic gastrointestinal cancer. Cancer Chemotherapy and Pharmacology 86:4, pages 547-558.
Crossref
Andreas A. Argyriou, Foteini Kalofonou, Pantelis Litsardopoulos, Garifallia G. Anastopoulou, Dimitri Psimaras, Jordi Bruna & Haralabos P. Kalofonos. (2020) Real world, open label experience with lacosamide against acute painful oxaliplatin‐induced peripheral neurotoxicity. Journal of the Peripheral Nervous System 25:2, pages 178-183.
Crossref
Ryo Otsuka, Satoru Iwasa, Takako Yanai, Hidekazu Hirano, Hirokazu Shoji, Yoshitaka Honma, Natsuko Okita, Atsuo Takashima, Ken Kato, Hironobu Hashimoto, Masatoshi Sekiguchi, Yoshinori Makino, Narikazu Boku & Masakazu Yamaguchi. (2019) Impact of peripheral neuropathy induced by platinum in first-line chemotherapy on second-line chemotherapy with paclitaxel for advanced gastric cancer. International Journal of Clinical Oncology 25:4, pages 595-601.
Crossref
Andreas A. Argyriou, Anna G. Antonacopoulou, Paola Alberti, Chiara Briani, Jordi Bruna, Roser Velasco, Garifallia G. Anastopoulou, Susanna B. Park, Guido Cavaletti & Haralabos P. Kalofonos. (2019) Liability of the voltage‐gated potassium channel KCNN3 repeat polymorphism to acute oxaliplatin‐induced peripheral neurotoxicity . Journal of the Peripheral Nervous System 24:4, pages 298-303.
Crossref
Nathan P. Staff, Guido Cavaletti, Badrul Islam, Maryam Lustberg, Dimitri Psimaras & Stefano Tamburin. (2019) Platinum‐induced peripheral neurotoxicity: From pathogenesis to treatment. Journal of the Peripheral Nervous System 24:S2.
Crossref
Elena Elez, Carlos Gomez-Roca, Arturo Soto Matos-Pita, Guillem Argiles, Thibaud Valentin, Cinthya Coronado, Jorge Iglesias, Teresa Macarulla, Sarah Betrian, Salvador Fudio, Katrin Zaragoza, Josep Tabernero & Jean-Pierre Delord. (2018) First-in-human phase I study of the microtubule inhibitor plocabulin in patients with advanced solid tumors. Investigational New Drugs 37:4, pages 674-683.
Crossref
Nur Izgu, Leyla Ozdemir & Fatma Bugdayci Basal. (2019) Effect of Aromatherapy Massage on Chemotherapy-Induced Peripheral Neuropathic Pain and Fatigue in Patients Receiving Oxaliplatin. Cancer Nursing 42:2, pages 139-147.
Crossref
Amina M. Illias, Andrea C. Gist, Haijun Zhang, Alyssa K. Kosturakis & Patrick M. Dougherty. (2018) Chemokine CCL2 and its receptor CCR2 in the dorsal root ganglion contribute to oxaliplatin-induced mechanical hypersensitivity. Pain 159:7, pages 1308-1316.
Crossref
Seda Kurt & Gulbeyaz Can. (2018) Reflexology in the management of chemotherapy induced peripheral neuropathy: A pilot randomized controlled trial. European Journal of Oncology Nursing 32, pages 12-19.
Crossref
Dawon ParkSe-Jin Baek, Jung-Myun KwakJin KimSeon-Hahn Kim. (2018) Analysis of reduced-dose administration of oxaliplatin as adjuvant FOLFOX chemotherapy for colorectal cancer. Annals of Surgical Treatment and Research 94:4, pages 196.
Crossref
Yukako Ito, Shinji Kobuchi, Risa Shimizu & Yosuke Katsuyama. (2017) Pharmacokinetic and toxicodynamic evaluation of oxaliplatin-induced neuropathy and hematological toxicity in rats. Cancer Chemotherapy and Pharmacology 81:1, pages 155-161.
Crossref
S.J.L. Flatters, P.M. Dougherty & L.A. Colvin. (2017) Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review. British Journal of Anaesthesia 119:4, pages 737-749.
Crossref
Tejaswi Kandula, Michelle A. Farrar, Matthew C. Kiernan, Arun V. Krishnan, David Goldstein, Lisa Horvath, Peter Grimison, Frances Boyle, Sally Baron-Hay & Susanna B. Park. (2017) Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer. Clinical Neurophysiology 128:7, pages 1166-1175.
Crossref
Ali Esfahani, Mohammad hossein Somi, Hormoz Ayromlou, Alireza Nikanfar, Mohammad Asghari Jafarabadi, Bina Eftekhar Sadat & Zohreh Ghoreishi. (2016) The effect of n-3 polyunsaturated fatty acids on incidence and severity of oxaliplatin induced peripheral neuropathy: a randomized controlled trial. Biomarker Research 4:1.
Crossref
Holly L. Hopkins, Natalie A. Duggett & Sarah J.L. Flatters. (2016) Chemotherapy-induced painful neuropathy. Current Opinion in Supportive & Palliative Care 10:2, pages 119-128.
Crossref
Ali Shahriari-Ahmadi, Ali Fahimi, Mehrdad Payandeh & Masoud Sadeghi. (2015) Prevalence of Oxaliplatin-induced Chronic Neuropathy and Influencing Factors in Patients with Colorectal Cancer in Iran. Asian Pacific Journal of Cancer Prevention 16:17, pages 7603-7606.
Crossref
Jessica A Boyette-Davis, Edgar T Walters & Patrick M Dougherty. (2015) Mechanisms involved in the development of chemotherapy-induced neuropathy. Pain Management 5:4, pages 285-296.
Crossref
Andreas Argyriou. (2015) Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN). Toxics 3:2, pages 187-197.
Crossref
Jin-Hee Park, Jisook Chae, Kangsan Roh, Eui-Joon Kil, Minji Lee, Chung-Kyun Auh, Myung-Ah Lee, Chang-Hwan Yeom & Sukchan Lee. (2015) Oxaliplatin-Induced Peripheral Neuropathy via TRPA1 Stimulation in Mice Dorsal Root Ganglion Is Correlated with Aluminum Accumulation. PLOS ONE 10:4, pages e0124875.
Crossref
S Ohkawa, T Okusaka, H Isayama, A Fukutomi, K Yamaguchi, M Ikeda, A Funakoshi, M Nagase, Y Hamamoto, S Nakamori, Y Tsuchiya, H Baba, H Ishii, Y Omuro, M Sho, S Matsumoto, N Yamada, H Yanagimoto, M Unno, Y Ichikawa, S Takahashi, G Watanabe, G Wakabayashi, N Egawa, M Tsuda, R Hosotani, C Hamada & I Hyodo. (2015) Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer. British Journal of Cancer 112:9, pages 1428-1434.
Crossref
Charles J. Vierck & Robert P. Yezierski. (2015) Comparison of operant escape and reflex tests of nociceptive sensitivity. Neuroscience & Biobehavioral Reviews 51, pages 223-242.
Crossref
Chiara Briani, Andreas A. Argyriou, Cristina Izquierdo, Roser Velasco, Marta Campagnolo, Paola Alberti, Barbara Frigeni, Mario Cacciavillani, Francesca Bergamo, Diego Cortinovis, Marina Cazzaniga, Jordi Bruna, Guido Cavaletti & Haralabos P. Kalofonos. (2014) Long-term course of oxaliplatin-induced polyneuropathy: a prospective 2-year follow-up study. Journal of the Peripheral Nervous System 19:4, pages 299-306.
Crossref
Marta Seretny, Gillian L. Currie, Emily S. Sena, Sabrina Ramnarine, Robin Grant, Malcolm R. MacLeod, Leslie A. Colvin & Marie Fallon. (2014) Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain 155:12, pages 2461-2470.
Crossref
R. Velasco, J. Bruna, C. Briani, A. A. Argyriou, G. Cavaletti, P. Alberti, B. Frigeni, M. Cacciavillani, S. Lonardi, D. Cortinovis, M. Cazzaniga, C. Santos & H. P. Kalofonos. (2013) Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients. Journal of Neurology, Neurosurgery & Psychiatry 85:4, pages 392-398.
Crossref
Satoshi OtsuYoshinori HirashimaKazuo NishikawaHiroyuki SakashitaRyotaro MorinagaKoichiro WatanabeKuniaki Shirao. (2014) Neurological Toxicity in Metastatic Colorectal Cancer Patients Treated with Modified FOLFOX6 plus Bevacizumab. Japanese Clinical Medicine 5, pages JCM.S15553.
Crossref
Tomoe Kanbara, Atsushi Nakamura, Keiko Takasu, Koichi Ogawa, Masahiro Shibasaki, Tomohisa Mori, Tsutomu Suzuki, Minoru Hasegawa, Gaku Sakaguchi & Toshiyuki Kanemasa. (2014) The Contribution of Gi/o Protein to Opioid Antinociception in an Oxaliplatin-Induced Neuropathy Rat Model. Journal of Pharmacological Sciences 126:3, pages 264-273.
Crossref
María Sereno, Gerardo Gutiérrez-Gutiérrez, César Gómez-Raposo, Miriam López-Gómez, Maria Merino-Salvador, Francisco Zambrana Tébar, Cristina Rodriguez-Antona & Enrique Casado. (2014) Oxaliplatin induced-neuropathy in digestive tumors. Critical Reviews in Oncology/Hematology 89:1, pages 166-178.
Crossref
Helena Maria de Cerqueira Mathias, Maria Cecília Mathias Machado & Adriano Celso Rodrigues. (2013) Neuropatia Periférica em Pacientes com Câncer Colorretal em Tratamento com Oxaliplatina. Revista Neurociências 21:3, pages 435-448.
Crossref
Nusrat Bano, Rahila Najam & Ahmed Mateen. (2013) Neurological Adverse Effects in Patients of Advanced Colorectal Carcinoma Treated with Different Schedules of FOLFOX. Chemotherapy Research and Practice 2013, pages 1-7.
Crossref
A. A. Argyriou, C. Briani, G. Cavaletti, J. Bruna, P. Alberti, R. Velasco, S. Lonardi, D. Cortinovis, M. Cazzaniga, M. Campagnolo, C. Santos & H. P. Kalofonos. (2012) Advanced age and liability to oxaliplatin‐induced peripheral neuropathy: post hoc analysis of a prospective study . European Journal of Neurology 20:5, pages 788-794.
Crossref
Jessica A. Boyette-Davis, Juan P. Cata, Larry C. Driver, Diane M. Novy, Brian M. Bruel, Deidre L. Mooring, Gwen Wendelschafer-Crabb, William R. Kennedy & Patrick M. Dougherty. (2012) Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristine. Cancer Chemotherapy and Pharmacology 71:3, pages 619-626.
Crossref
Andreas A. Argyriou, Guido Cavaletti, Chiara Briani, Roser Velasco, Jordi Bruna, Marta Campagnolo, Paola Alberti, Francesca Bergamo, Diego Cortinovis, Marina Cazzaniga, Cristina Santos, Konstantinos Papadimitriou & Haralabos P. Kalofonos. (2012) Clinical pattern and associations of oxaliplatin acute neurotoxicity. Cancer 119:2, pages 438-444.
Crossref
A.A. Argyriou, R. Velasco, C. Briani, G. Cavaletti, J. Bruna, P. Alberti, M. Cacciavillani, S. Lonardi, C. Santos, D. Cortinovis, M. Cazzaniga & H.P. Kalofonos. (2012) Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients. Annals of Oncology 23:12, pages 3116-3122.
Crossref
Andreas A. Argyriou, Jordi Bruna, Paola Marmiroli & Guido Cavaletti. (2012) Chemotherapy-induced peripheral neurotoxicity (CIPN): An update. Critical Reviews in Oncology/Hematology 82:1, pages 51-77.
Crossref
Miki Takeshita, Yoshiko Banno, Mitsuhiro Nakamura, Mayuko Otsuka, Hitomi Teramachi, Teruo Tsuchiya & Yoshinori Itoh. (2011) The Pivotal Role of Intracellular Calcium in Oxaliplatin-Induced Inhibition of Neurite Outgrowth but Not Cell Death in Differentiated PC12 Cells. Chemical Research in Toxicology 24:11, pages 1845-1852.
Crossref
Barbara Frigeni, Marialuisa Piatti, Francesca Lanzani, Paola Alberti, Patrizia Villa, Claudio Zanna, Maurizio Ceracchi, Massimo Ildebrando & Guido Cavaletti. (2011) Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale. Journal of the Peripheral Nervous System 16:3, pages 228-236.
Crossref
Joan Elizabeth Cunningham, Teresa Kelechi, Katherine Sterba, Nikki Barthelemy, Paul Falkowski & Steve H. Chin. (2011) Case report of a patient with chemotherapy-induced peripheral neuropathy treated with manual therapy (massage). Supportive Care in Cancer 19:9, pages 1473-1476.
Crossref
J. Boyette-Davis & P.M. Dougherty. (2011) Protection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocycline. Experimental Neurology 229:2, pages 353-357.
Crossref
Guido Cavaletti, Paola Alberti, Barbara Frigeni, Marialuisa Piatti & Emanuela Susani. (2010) Chemotherapy-Induced Neuropathy. Current Treatment Options in Neurology 13:2, pages 180-190.
Crossref
Andrew Weickhardt, Keith Wells & Wells Messersmith. (2011) Oxaliplatin-Induced Neuropathy in Colorectal Cancer. Journal of Oncology 2011, pages 1-7.
Crossref
A. G. Antonacopoulou, A. A. Argyriou, C. D. Scopa, A. Kottorou, A. Kominea, S. Peroukides & H. P. Kalofonos. (2010) Integrin beta‐3 L33P: a new insight into the pathogenesis of chronic oxaliplatin‐induced peripheral neuropathy?. European Journal of Neurology 17:7, pages 963-968.
Crossref
R. Velasco & J. Bruna. (2010) Chemotherapy-induced peripheral neuropathy: An unresolved issue. Neurología (English Edition) 25:2, pages 116-131.
Crossref
R. Velasco & J. Bruna. (2010) Neuropatía inducida por quimioterapia: un problema no resuelto. Neurología 25:2, pages 116-131.
Crossref
Guido Cavaletti, Barbara Frigeni, Francesca Lanzani, Laura Mattavelli, Emanuela Susani, Paola Alberti, Diego Cortinovis & Paolo Bidoli. (2010) Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools. European Journal of Cancer 46:3, pages 479-494.
Crossref
N. Attal, D. Bouhassira, M. Gautron, J. N. Vaillant, E. Mitry, C. Lepère, P. Rougier & F. Guirimand. (2009) Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: A prospective quantified sensory assessment study. Pain 144:3, pages 245-252.
Crossref
Susanna B. ParkDavid GoldsteinCindy S.-Y. LinArun V. KrishnanMichael L. FriedlanderMatthew C. Kiernan. (2009) Acute Abnormalities of Sensory Nerve Function Associated With Oxaliplatin-Induced Neurotoxicity. Journal of Clinical Oncology 27:8, pages 1243-1249.
Crossref
Anthony Behin, Dimitri Psimaras, Khe Hoang-Xuan & Jean-Marc Leger. (2008) Neuropathies in the context of malignancies. Current Opinion in Neurology 21:5, pages 534-539.
Crossref
Andreas A. Argyriou, Panagiotis Polychronopoulos, Gregoris Iconomou, Elisabeth Chroni & Haralabos P. Kalofonos. (2008) A review on oxaliplatin-induced peripheral nerve damage. Cancer Treatment Reviews 34:4, pages 368-377.
Crossref
Andreas A. Argyriou, Panagiotis Polychronopoulos & Elisabeth Chroni. (2007) The Usefulness of Nerve Conduction Studies in Objectively Assessing Oxaliplatin-Induced Peripheral Neuropathy. The Oncologist 12:11, pages 1371-1372.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.